A rare curative case of collecting duct carcinoma
- Resource Type
- article
- Authors
- Tielin Wu; Min Yin; Harris Haleem
- Source
- Urology Case Reports, Vol 41, Iss , Pp 101981- (2022)
- Subject
- Immunotherapy
Nivolumab
Collecting duct carcinoma
Sorafenib
Diseases of the genitourinary system. Urology
RC870-923
- Language
- English
- ISSN
- 2214-4420
Collecting duct carcinoma (CDC) is a rare form of renal carcinoma that has a poor prognosis. To date, there has been no report that the survival time of a patient with metastatic CDC could be more than six years. We present a case of rapidly advanced recurrence of CDC after nephrectomy that completely responded surgical intervention followed by targeted therapy with sorafenib and nivolumab.